Pharmaceutical Stewardship Act of 2016

Bill: 114-hr-4931
Sponsor: full_name: Rep. Slaughter, Louise McIntosh [D-NY-25]
Introduced: 2016-04-13
Policy area: Crime and Law Enforcement
Subjects: Drug trafficking and controlled substances

Prescription drugs

User charges and fees
Latest action: action_date: 2016-04-15
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2016-04-13
action_desc: Introduced in House
text: <p><b style="">Pharmaceutical Stewardship Act of 2016</b><br /></p> <p>This bill requires the Drug Enforcement Administration to establish and implement a national pharmaceutical stewardship program to collect and dispose of prescription medications. </p>

tv_txt: I 114th CONGRESS 2d Session H. R. 4931 IN THE HOUSE OF REPRESENTATIVES April 13, 2016 Ms. Slaughter introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To direct the Attorney General to establish a national pharmaceutical stewardship program to facilitate the collection and disposal of prescription medications.

1. Short title This Act may be cited as the Pharmaceutical Stewardship Act of 2016 . 2. National pharmaceutical stewardship program (a) In general The Attorney General, acting through the Administrator of the Drug Enforcement Administration, shall establish and implement a national pharmaceutical stewardship program to facilitate the collection and disposal of prescription medications at the locations at which such prescription medications are dispensed. (b) Annual fees (1) In general The Attorney General may assess, collect, and use, without further appropriation, annual fees from producers of prescription medications to pay the administrative costs of carrying out this section. (2) Amount of fees The Attorney General shall allocate the amount of fees under this subsection among the producers of prescription medications in a manner that provides for a fair and reasonable allocation of the costs of carrying out this section across such producers.